Edition:
United Kingdom

BeyondSpring Inc Posts Qtrly Loss Per Share of $0.64


Tuesday, 30 Apr 2019 

April 30 (Reuters) - BeyondSpring Inc ::BEYONDSPRING PROVIDES BUSINESS UPDATE AND FOURTH QUARTER AND FULL-YEAR 2018 FINANCIAL RESULTS.BEYONDSPRING INC - QTRLY LOSS PER SHARE $0.64.BEYONDSPRING - ON TRACK TO SUBMIT NDAS FOR PLINABULIN TO CHINA'S NMPA FOR NON-SMALL CELL LUNG CANCER & CHEMOTHERAPY-INDUCED NEUTROPENIA IN Q4 2019.BEYONDSPRING INC - ON TRACK TO SUBMIT NDA FOR PLINABULIN TO U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR BOTH INDICATIONS IN 2020. 

Company Quote

16.33
0.28 +1.74%
19 Jul 2019